Assumptions regarding the true underlying genetic model, or mode of inheritance, are necessary when quantifying genetic associations with disease phenotypes. Here we propose new methods to ascertain the underlying genetic model from parental data in family-based association studies. Specifically, for parental mating-type data, we propose a novel statistic to test whether the underlying genetic model is additive, dominant, or recessive; for parental genotype-phenotype data, we propose three strategies to determine the true mode of inheritance. We illustrate how to incorporate the information gleaned from these strategies into family-based association tests. Because family-based association tests are conducted conditional on parental genotypes, the type I error rate of these procedures is not inflated by the information learned from parental data. This result holds even if such information is weak or when the assumption of Hardy-Weinberg equilibrium is violated. Our simulations demonstrate that incorporating parental data into family-based association tests can improve power under common inheritance models. The application of our proposed methods to a candidate-gene study of type 1 diabetes successfully detects a recessive effect in MGAT5 that would otherwise be missed by conventional family-based association tests.
INTRODUCTION
In genetic association studies, especially genome-wide association studies (GWASs), genetic markers are routinely tested under the assumption of additive effects. For example, the commonly used transmission disequilibrium test (TDT) (Spielman and others, 1993 ) is a score test assuming multiplicative genotyperelative risks (GRRs; additive on the log-scale) using conditional logistic regressions (Schaid and Sommer, 1993; Self and others, 1991) . For case-control studies, when Hardy-Weinberg equilibrium (HWE) the mating types to estimate the effect sizes (Murphy and others, 2008) . The parental phenotypes, when available, can also be used to prioritize SNPs for family-based association tests (Qin and others, 2010) . Another way of using parental information is to combine the parental genotype-phenotype information with family-based association tests (Purcell and others, 2005) ; however, this approach does not guarantee complete robustness against population stratification.
In this article, we focus on incorporating parental information to construct tests that are robust against both population stratification and the true underlying genetic model. Our article is outlined as follows. In Section 2, we present strategies to infer genetic models from parental-mating-type data or parental genotype-phenotype data. In Section 3, we present the results of a simulation study that demonstrates the advantage of our proposed methods. A real example is presented in Section 4, where we show that our methods successfully detect a recessive effect that would not have been detected by standard methods. The article concludes with a discussion of our proposed methodology and avenues for future work.
METHODS
Consider an SNP that follows HWE in the population. Let A and B denote the risk and the reference allele, respectively, and let p denote the frequency of allele A in the population. When the order of the two parents is ignored, there are six possible mating types, as shown in the second column of Table S1 in supplementary material available at Biostatistics online. We use n i , i = 1, 2, 2, . . ., to denote the number of couples that fall in the ith mating type among n total couples. Let e β 0 be the risk of disease for subjects with the BB genotype and define e β 1 = Pr(D|AB)/ Pr(D|BB), e β 2 = Pr(D|AA)/ Pr(D|BB).
Thus, e β 1 is the GRR of genotype AB to genotype BB and e β 2 is the GRR of genotype AA to genotype BB. Let G P and G O be the genotypes of the parents and the genotypes of the offspring, respectively; let D P and D O be the disease statuses of the parents and the offspring, respectively. In a case-parents study, a family is ascertained because the offspring is affected, i.e., D O = 1. The population frequencies of mating types can then be expressed in terms of p, β 1 , and β 2 , as shown in Column 1 of Table S1 in supplementary material available at Biostatistics online (Schaid and Sommer, 1993) . It has previously been noted that the likelihood of family data can be factored (Clayton, 1999; Whittemore and Tu, 2000) . Specifically, with the assumption that the disease statuses of the family members are conditionally independent given their genotypes, the factorization is as follows:
Thus the information in case-parents data can be partitioned into three independent components: L NF (β 1 , β 2 ), the non-founder likelihood that is used to construct family-based association tests such as the TDT; L M ( p, β 1 , β 2 ), the likelihood based upon mating-type data; and L PGP (β 0 , β 1 , β 2 ), the likelihood based upon parental genotype-phenotype data. Note that the β i 's in L PGP (β 0 , β 1 , β 2 ) denote log-odds ratios, rather than log-GRRs. Although GRRs and odds ratios are not identical, they are approximately the same for rare diseases, and we expect that they provide similar information regarding the mode of inheritance. 
The non-founder likelihood
The non-founder likelihood leads to a conditional approach (Schaid and Sommer, 1993; Self and others, 1991) . By conditioning on parental genotypes, , where n i j is the number of families with the ith mating type and jth offspring type, as shown in the first column of Table S1 in supplementary material available at Biostatistics online. The widely used TDT is the score test derived under the assumption of the additive model (Schaid and Sommer, 1993) . In this article, the additive model refers to the additivity of the log-GRRs, i.e., β 2 = 2β 1 , and we denote the resulting test ADD. Two other score tests, DOM, which assumes the dominant model, i.e., β 1 = β 2 , and REC, which assumes the recessive model, i.e., β 1 = 0, can be derived similarly (Zheng and others, 2002; Schaid and Sommer, 1993) . We define ADD, DOM, and REC to be the signed square-root of the above score statistics, given by
Under the null hypothesis of no association, all three test statistics are asymptotically distributed as standard normal random variables. Their asymptotic correlations under the null hypothesis of no association can be derived using the delta method and are estimated by Zheng and others (2002) corr(ADD,DOM) = 2n 4 + 2n 5 √ (3n 4 + 4n 5 )(n 2 + 2n 4 + n 5 ) ,
Under the null hypothesis of no association, the joint distribution of the three test statistics can be approximated by the multivariate normal distribution with the above pairwise correlations. The significance of both MERT and MAX3 can be evaluated using this approximation. In MAX3, the maximum of |ADD|, |DOM|, and |REC| is used as a test statistic and its p-value can be calculated using double integrals based on the multivariate normal approximation (Zheng and others, 2002) .
Another robust statistic we consider in this article is the score test statistic with two degrees of freedom (Schaid and Sommer, 1993) : 
The Fisher information matrix of the mating-type likelihood is ill-conditioned (Murphy and others, 2008) .
However, the following section shows that mating-type data can provide useful information about the true underlying genetic model when we put restrictions on the parameters using the dominant or recessive model.
2.2.1
The information in mating-type data.
PROPOSITION 1 Mating-type data provide no information for association tests of additive genetic effects.
The assumption of additive effects implies β 2 = 2β 1 = 2β. In Section A of the Supplementary material, we showed that Rao's efficient score (Rao, 1948) is always zero and the expectation of the determinant of the Fisher information matrix is zero. Thus, under the additive model, there is no information regarding β in mating-type data. At first glance, this might seem surprising. One explanation is that for both the null hypothesis of no genetic association and the additive model, the mating types follow random mating, i.e., the probability of a mating type equals the product of genotype probabilities of two parents. This result is established in Section A of the Supplementary material.
. Z follows the standard normal distribution asymptotically when the GRRs are log-additive, i.e., β 2 = 2β 1 . Furthermore, the sign of its expectation depends on the true underlying genetic model.
As a result, the expectation of Z is positive when the true model is recessive and negative when the true model is dominant.
This test statistic was motivated by the fact that the score under the recessive genetic model has a zero expectation not only when β 2 = β 1 = 0, but also when β 2 = 2β 1 > 0. Based on this observation, we can normalize the score to obtain Z as a test of the hypothesis that the true GRRs are log-additive. The derivation and proof are provided in Section B of the Supplementary material.
In the numerator of Z , (p 1 +p 2 /2 +p 4 /4) is the expected frequency of AA children under nonpreferable transmission given parental mating-type data, whilep 2 is the expected frequency of AA children under non-preferable transmission given the pool of parental alleles. The latter term also implies random mating of parents and is therefore stronger than the first. It follows that the difference is expected to be zero when the ascertained parents show random mating. We have shown in Section A of the Supplementary material that the ascertained parents show random mating when the true underlying effect is additive. As the additive model includes no association as a special case, Z is asymptotically distributed as a standard normal random variable when there is either no genetic association or an additive association, and it has a non-zero mean when the two alleles interact with one another.
2.2.2 Model selection and elimination based on mating-type data. Proposition 2 indicates that Z provides useful information for the true underlying model. To take advantage of this, we propose a modelselection-elimination (MSE) approach, which is depicted in Figure 1 . As shown in Figure 1 , we perform an extreme test (DOM or REC) when there is sufficient evidence of the corresponding genetic model from Z ; when the absolute value of Z is not large, here we choose the cutoff value of 1, indicating that the additive model is highly plausible, we perform ADD; when there is moderate evidence supporting one extreme model, we eliminate the opposite model and evaluate the significance based on the more significant one of the two remaining models. For example, when is Z is 1.5, we take the larger value of |ADD| and |REC|, and similar to MAX3, we use the asymptotic correlation corr(ADD, REC) (provided in Section 2.1) and the cumulative density function of a bivariate normal distribution to obtain the resulting p-value. Here, the Z cutoffs of 1 and 2 are chosen so that we have approximately 70% chance of choosing the correct model and 5% chance of choosing one of the two extreme models when the true mode is additive. MSE uses information in mating-type data to choose a plausible model and uses transmission to ultimately test the genetic association. Importantly, because the information in mating is independent of that in transmission, the size of the MSE testing procedure is not inflated relative to the nominal type I error rate.
2.2.3 When the risk allele is unknown. The sign of E[Z ] depends on the sign of β 2 − 2β 1 . In the previous section, we assumed that the reference allele, allele B in our notation, is the low-risk allele and the test allele, allele A in our notation, is the high-risk allele. This implies that β 1 0 and β 2 0. In this case, β 2 − 2β 1 > 0 holds for a recessive model, while β 2 − 2β 1 < 0 holds for a dominant model. In contrast, when the test allele is a low-risk allele, we have β 1 0 and β 2 0, which leads to E[Z ] being positive for a dominant model and E[Z ] being negative for a recessive model. A similar behavior was observed with the HWE test in a case-control design (Joo and others, 2010) . Thus, when the risk allele is unknown, care must be taken to distinguish between the dominant and recessive model. Here, we use one allele arbitrarily as the reference allele and the other one as the test allele. We first calculate ADD and Z , then replace Z with sign(ADD)Z . This ensures that a positive Z indicates a recessive effect and a negative Z indicates a dominant effect.
The parental genotype-phenotype likelihood
When phenotypes of parents are available, they may provide useful information regarding the true underlying genetic model. Let r 0 , r 1 , and r 2 denote the number of affected parents with genotype BB, AB, and AA, respectively, and let s 0 , s 1 , and s 2 denote the number of unaffected parents with genotype BB, AB, and AA, respectively. The parental genotype-phenotype likelihood is then: (Armitage, 1955) , which is the score test that is commonly used for case-control association studies (Sasieni, 1997) . Let 2DF PGP , ADD PGP , DOM PGP , and REC PGP be the score tests under no restrictions, an additive effect, a dominant effect, and a recessive effect, respectively. Here, the subscript "PGP" stands for "parental genotype-phenotype," and we consider the signed square-root of the test statistics for ADD PGP , DOM PGP , and REC PGP . When phenotypes of parents are available, we first perform the above-mentioned four tests and then use the results to determine which test will be performed for the non-founder likelihood. We propose three strategies: (i) model-selection (MS); (ii) weighted test (WT); and (iii) model-elimination (ME). Since both mating-type and parental genotype-phenotype data contain information for mode of inheritance, we propose a method, called MSE M-PGP , to combine the information in these data. The details of these methods can be found in Section C of the Supplementary material.
Generalization to nuclear families
The proposed methods can also be applied to nuclear families containing more than one affected or unaffected child per family by using the following testing algorithm. As before, we first use either matingtype data or parental genotype-phenotype data to infer the genetic model. Note that the mating-type data provide useful information of the genetic model as long as the families are ascertained through a diseased offspring and parental genotype-phenotype data provide information of the genetic model regardless of ascertainment. We then perform family-based association tests by assuming different genetic models by appropriately coding the genotypes to numerical values or vectors (Horvath and others, 2001) . As in Rabinowitz and Laird (2000) , missing data in parents are addressed by conditioning on the sufficient statistics. Finally, we use the information of genetic models inferred from parental data to combine family-based association tests under different genetic models.
SIMULATIONS AND SIMULATION RESULTS

Methods of simulations
In most simulations, we assume that 1000 case-parents trios are sampled from a random mating population. Three disease models are considered: additive, dominant, and recessive. The frequencies of the risk allele are chosen at 0.1, 0.2, and 0.3. Two p-value cutoffs are considered in this article: 0.05 and 1.0E−7. A cutoff of 0.05 corresponds to the significance level used for an individual test, and 1.0E−7 corresponds to the significance level used for a GWAS. Noting that the information in the phenotypes of parents depends on the prevalence of the disease in the general population, we consider prevalence values of 5, 10, and 15%. For each combination of parameters, we choose GRRs such that the power of the optimal test is close to 0.9.
The GRR parameters are provided in the footnotes of Table 1-3 and Table S2 in supplementary material available at Biostatistics online. In each scenario, power is empirically estimated using 1000 simulated datasets.
To study the effect of population stratification, we conduct simulations assuming that trios are sampled from two random mating populations, with the frequencies of the risk allele being 0.1 and 0.2, respectively. In this case, we sample 500 trios from Population 1 and 500 from Population 2.
Simulation results
3.2.1 Accuracy in selecting or eliminating models. We first examine whether mating-type data and parental genotype-phenotype data provide additional information to facilitate model selection and elimination. A comparison of Table 1-3 and Table S2 in supplementary material available at Biostatistics online shows that the larger the effect sizes, the larger the probability of selecting the true model and eliminating the wrong model. For example, when the true model is recessive and the frequency of the risk allele is 0.2, the proportion of simulations in which REC was correctly selected based on Z increased from 42% for β 2 = log(1.75) to 94% for β 2 = log(2.73). For parental genotype-phenotype data, the larger the prevalence the higher the chance of selecting the true model and eliminating the wrong model. For example, when the true model is recessive, the frequency of the risk allele is 0.1 and β 2 = log(2.70), the proportion of simulations in which REC is chosen as the most likely model using parental genotype-phenotype data increased from 64% for a 5% prevalence to 92% for a 15% prevalence.
In the presence of population stratification, the information in mating-type data or that in parental genotype-phenotype data tends to predict the model to be recessive (Table S5 in supplementary material available at Biostatistics online). This observation implies that violation of HWE leads to biased inference for the mode of inheritance when using mating-type or parental genotype-phenotype data. Tables 4-6 and Table S3 in supplementary material available at Biostatistics online. The first three columns yield the empirical power of the tests under the additive, dominant, and recessive model, respectively. It is not surprising that all tests are optimal when the assumed model agrees with the true model, but none of them are robust against model misspecification. Similar to what has been previously reported, we found that MAX3 is more powerful than 2DF in all situations. For large effect sizes (Table S3 in supplementary material available at Biostatistics online) MSE has greater power than MAX3 when the true model is recessive. When the effect sizes are small (Tables 4-6), MSE generally outperforms MAX3 when the true model is additive or dominant, but is less powerful when the true model is recessive. Since the additive model is probably the most common model (Vukcevic and others, 2011; Hill and others, 2008) , we expect that MSE would outperform MAX3 in many commonly encountered scenarios.
Empirical power. Estimated power is presented in
The performance of the three methods that use information from parental genotype-phenotype data is highly dependent on effect size and prevalence. Compared with MSE and the two previously published methods, the MS and WT approaches have lower power when the prevalence of the disease is not high; ME has satisfactory performance when the true model is additive or dominant, especially when the prevalence is high or when the effect size is large. Among the three methods that use parental genotype-phenotype information, ME (the method that eliminates the least likely model) has the best overall performance, and MS (the method that selects the most likely model) has the poorest overall performance.
As expected, the proposed tests maintain the correct type I error rate in the presence of population stratification (Table 6S in supplementary material available at Biostatistics online). However, the power of the tests when the true underlying model is additive or dominant is reduced. This is not surprising, as we have seen that mating type or parental genotype-phenotype data tend to choose the recessive model in the presence of population stratification. We also examined the performance of combining information in mating type and parental genotypephenotype data. The results in Table S7 in supplementary material available at Biostatistics online show that there is either no or very small improvement in MSE M-PGH over MSE. This agrees with our observation (Tables 4-6 and Table S3 in supplementary material available at Biostatistics online) that methods based on parental genotype-phenotype data usually have no greater power than MSE.
A REAL EXAMPLE
Type 1 diabetes [T1D, MIM 222100] is an auto-immune disease with a world-wide prevalence ranging from 1 to 17 cases per 100 000 subjects. More than 40 loci have been identified for T1D, such as variants in cytotoxic T-lymphocyte antigen-4 (CTLA-4, rs231775), interleukin-2 receptor-α (IL-2RA, rs2104286), and interleukin-7 receptor-α (IL-7RA, rs6897932) (Visscher and others, 2012) . In addition to these genes, our past work has also considered variants in the Golgi N-glycosylation enzymes MGAT1 and MGAT5. We recently reported that the CTLA-4, IL2RA, and IL7RA variants alter N-glycosylation and interact with a haplotype of MGAT1 (MGAT1 IV A V T-T ) to regulate T-cell function and risk of multiple sclerosis (MS), an autoimmune disease of the central nervous system (Mkhikian and others, 2011) . Deficiency of MGAT5 in mice leads to T-cell hyper-activity and spontaneous autoimmunity (Demetriou and others, 2001; Lee and others, 2007) , while two linked intronic human MGAT5 polymorphisms (rs4953911 and rs3814022) were the top hits in a GWAS for MS severity (Brynedal and others, 2010) . We genotyped seven SNPs at the five genes (two at MGAT1, one at CTLA4, one at IL-2RA, one at IL-7RA, and two at MGAT5) for nuclear families recruited by the Type 1 Diabetes Genetics Consortium, using methods described previously (Mkhikian and others, 2011) . Each family enrolled in this study was ascertained through a diseased case and only families with at least two affected children remained in the study. In total, data are available on 9367 subjects from 2395 Caucasian families.
We used the 1429 families that have both parents genotyped to calculate the Z statistics. Their values are shown in Table 7 . Using our MSE approach, we conducted the additive test at three SNPs and the recessive test at one SNP. We also eliminated the dominant test at two SNPs and the recessive test at one SNP. Thus, the additive model is the most common model, which agrees with previous findings (Vukcevic and others, 2011; Hill and others, 2008) . We used the FBAT software (Laird and others, 2000) to conduct familybased association tests under different genetic models. The p-values of the MSE approach are smaller than those from MAX3, suggesting that incorporating the information in Z does lead to some gain in efficiency. One finding of particular interest is SNP rs3814022 at MGAT5. This SNP is not significant under the additive or the dominant model. Because the resulting Z value is 2.09, our MSE method tested the SNP using the recessive model. The resulting p-value is 1.5E−3, which is significant at level 0.05 after Bonferroni's correction for multiple comparisons. It is important to point out that the MGAT5 gene appears to also show a recessive pattern in our biological experiments (data unpublished). Although the Z statistic for the other SNP at MGAT5 (rs4953911) is not large enough to choose the recessive model, it does eliminate the dominant model. Thus, our MSE approach not only provides the strongest significance but also likely identifies the true underlying model for rs3814022.
Among the three SNPs showing additive effects based upon Z , two of them show the strongest evidence with the additive effect. The additive p-values in these two cases were 2.4E−5 for rs231775 (CTLA4) and 5.6E−7 for rs2104286 (IL-2RA). Association for both of these SNPs with T1D has been previously reported (Nistico and others, 1996; WTCCC-Consortium, 2007) .
Lastly, we examined how useful the information in parental genotype-phenotype data is for model selection or elimination. The p-values based on the information in parental genotype-phenotype data are usually greater than those based on our MSE approach or those calculated from MAX3, suggesting that the information in parental genotype-phenotype is perhaps less useful than that in parental mating type. This is not surprising, as there are only 137 affected parents among the 3404 parents whose phenotypes are known.
DISCUSSION
In this article, we proposed to improve the robustness of association tests for family-based data by inferring the true underlying model from parental data. The test statistic we proposed uses information from parental mating-type data. Because it follows the standard normal distribution asymptotically when the true underlying genetic model is additive, it can be used as a test for the mode of inheritance. Our simulations indicate that the proposed statistic provides considerable information in selecting the true model and eliminating the wrong model. As a result, our proposed MSE testing procedure has satisfactory robustness. The comparison of MSE with ADD indicates that MSE is a safe replacement of ADD. Although MSE has reduced power relative to 2DF and MAX3 when the true model is recessive and the effect size is moderate, it has improved power over 2DF and MAX3 when the true effect is additive. Given that most markers appear to show the strongest association for the additive effect, we expect that MSE outperforms 2DF and MAX3 in most situations. The application of MSE to a real data set detected a recessive SNP that would not have been identified using the additive test. The proposed Z test and the HWE test for cases share several similarities but are distinct in many other ways. For example, both of them provide information for the underlying genetic model; both have no power for additive effects; and both assume that the underlying population is a homogenous and random mating population such that HWE holds. One important distinction between the two is that Z is calculated using parental mating type, and hence it is statistically independent of family-based association tests. In the presence of population stratification, the mating-type distribution can be distorted, leading to an excess of spouse pairs with the same genotypes (Sebro and others, 2010; Yasuda, 1968) . In this situation, the chance that Z leads to the optimal test is reduced. However, because of the independence between Z and the family-based association test, the decision made based on Z might affect power but will not inflate type I error rates. In practice, SNPs with large HWE deviations are usually screened out before statistical analysis. As a result, the impact due to violation of HWE should be minimal and we anticipate that the proposed method is still valuable in the presence of HWE violation.
Finally, the performance of the methods that incorporate parental genotype-phenotype data depends on the specific strategy, the allele frequency, and the disease prevalence. When the prevalence of a target disease is large, all three strategies work well because there is sufficient information in the parental genotype-phenotype data to glean the true underlying genetic model. In our candidate-gene study of T1D, the number of T1D cases in parents was small. Thus, there was no substantial advantage of using parental genotype-phenotype data for this example. We proposed a method (MSE M-PGP ) to combine the matingtype and parental genotype-phenotype data. However, doing so does not provide improvements over methods based on mating-type data only. One likely explanation for this observation is that detecting interactions using case-control studies requires large sample sizes, whereas, in our case, dominant and recessive models can be considered as intra-locus interactions. Further investigation is needed to search for strategies that can better use all information available in family data.
An R program that implements our methods is available upon request.
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